bell
The current prices are delayed by 15 mins, login to check live prices.
Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd

(AJANTPHARM)

₹3121.150.88%

as on 04:01PM, 18 Sep 2024

Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 11 analysts

BUY

81.82%

Buy

9.09%

Hold

9.09%

Sell

Based on 11 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹2682.55

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share analysis

Ajanta Pharma Ltd price forecast by 11 analysts

Downside of-14.81%

High

₹3165

Target

₹2682.55

Low

₹1981

Ajanta Pharma Ltd target price ₹2682.55, a slight downside of -14.81% compared to current price of ₹3121.15. According to 11 analysts rating.

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹3,090.05
    ₹3,172.7
  • 52 Week's Low

    52 Week's High

    ₹1,650.05
    ₹3,485
1 Month Return+ 7.36 %
3 Month Return+ 30.51 %
1 Year Return+ 88.9 %
Previous Close₹3,149.00
Open₹3,149.00
Volume1.35L
Upper Circuit-
Lower Circuit-
Market Cap₹39,334.82Cr

Key Statistics

P/E Ratio46.42
PEG Ratio2.44
Market Cap₹39,334.82 Cr
P/B Ratio8.28
EPS64.6
Dividend Yield2.29
SectorPharmaceuticals
ROE24.24

Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹39,334.82 Cr69.13%0.51₹816 Cr₹4,208 Cr
BUY₹16,557.65 Cr4.78%0.52₹602 Cr₹2,851 Cr
BUY₹90,964.04 Cr30.18%0.56₹3,168 Cr₹29,001 Cr
HOLD₹1,11,787.57 Cr72.1%0.64₹3,854 Cr₹19,547 Cr
BUY₹61,329.09 Cr38.09%0.53NANA

Company Information

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Share Price: ₹3121.15 per share as on 18 Sep, 2024 04:01 PM
Market Capitalisation: ₹39,334.82Cr as of today
Revenue: ₹1,144.92Cr as on June 2024 (Q2 24)
Net Profit: ₹245.77Cr as on June 2024 (Q2 24)
Listing date: 05 Jun, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Ajanta Pharma Ltd

  • Ajanta Pharma Shows Bullish Momentum Post-Consolidation - 02 Sep, 2024

    Ajanta Pharma Ltd has rallied 50% over the last six months, recently breaking out from a bullish Flag pattern. Despite mild consolidation in August, experts recommend buying the stock with a target of Rs 3,384 in the next 3-4 weeks.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AJANTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 7.76% to 7.94% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.08K Cr → 1.17K Cr (in ₹), with an average increase of 7.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 202.72 Cr → 245.77 Cr (in ₹), with an average increase of 17.5% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 66.21% to 66.27% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.76% to 14.84% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 146.7% return, outperforming this stock by 33.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.54% to 8.36% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AJANTPHARM stock has moved down by -7.1%

Company Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹1,021.04Cr (-)₹1,028.44Cr (↑0.72%)₹1,105.15Cr (↑7.46%)₹1,054.08Cr (↓4.62%)₹1,144.92Cr (↑8.62%)
Net Income₹208.12Cr (-)₹195.30Cr (↓6.16%)₹210.03Cr (↑7.54%)₹202.72Cr (↓3.48%)₹245.77Cr (↑21.24%)
Net Profit Margin20.38% (-)18.99% (↓6.82%)19.00% (↑0.05%)19.23% (↑1.21%)21.47% (↑11.65%)
Value in ₹ crore
Details2021202220232024
Total Assets₹3,532.06Cr (-)₹3,808.64Cr (↑7.83%)₹4,339.09Cr (↑13.93%)₹4,252.44Cr (↓2.00%)
Total Liabilities₹647.08Cr (-)₹639.46Cr (↓1.18%)₹1,092.64Cr (↑70.87%)₹838.87Cr (↓23.23%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹300.88Cr (-)₹466.99Cr (↑55.21%)₹542.34Cr (↑16.14%)₹736.29Cr (↑35.76%)₹735.35Cr (↓0.13%)

Index Inclusions

BSE Healthcare

₹43,763.48

-1.23 (-544.38%)

S&P BSE 150 MidCap

₹16,861.43

-0.74 (-126.15%)

Nifty LargeMidcap 250

₹16,673.25

-0.45 (-74.8%)

BSE Mid-Cap

₹48,857.07

-0.71 (-349.75%)

S&P BSE 400 MidSmallCap

₹12,848.57

-0.62 (-80.01%)

BSE 500

₹37,668.29

-0.37 (-138.15%)

S&P BSE AllCap

₹11,026.27

-0.37 (-41.39%)

Nifty Midcap 150

₹22,079.90

-0.7 (-155.45%)

Nifty MidSmallcap 400

₹20,837.05

-0.57 (-119.45%)

S&P BSE 250 LargeMidCap

₹11,133.40

-0.36 (-40.47%)

Nifty 500

₹23,898.65

-0.3 (-71.25%)

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66.27%
0.09
Foreign Institutions
8.36%
-2.09
Mutual Funds
14.84%
0.56
Retail Investors
7.94%
2.36
Others
2.58%
-5.29

Key Indicators

Details20202021202220232024
Book Value Per Share (₹)197.56229.68253.5268.14282.34
Details20202021202220232024
Earning Per Share (₹)35.5550.1355.3446.5464.6
Details20202021202220232024
Return On Equity %19.1725.2823.7817.4224.24
Details20202021202220232024
Return On Assets %15.3418.5118.7113.5519.19

Ajanta Pharma Ltd Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (46.42x)

September 17, 2024

Industry (58.70x)

September 17, 2024

Highest (50.52x)

September 10, 2024

LowHigh

Earnings and Dividends

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 18.09% since last year same period to ₹245.77Cr in the Q1 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated 21.24% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends January,2024

    In the quarter ending December 2023, Ajanta Pharma Ltd has declared dividend of ₹26 - translating a dividend yield of 1.62%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ajanta Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Ajanta Pharma Ltd shares.

Ajanta Pharma Ltd (AJANTPHARM) share price today is ₹3121.15

Ajanta Pharma Ltd is listed on NSE

Ajanta Pharma Ltd is listed on BSE

  • Today’s highest price of Ajanta Pharma Ltd is ₹3172.7.
  • Today’s lowest price of Ajanta Pharma Ltd is ₹3090.05.

PE Ratio of Ajanta Pharma Ltd is 46.42

PE ratio = Ajanta Pharma Ltd Market price per share / Ajanta Pharma Ltd Earnings per share

Today’s traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 1.35L.

Today’s market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹39334.82Cr.

Ajanta Pharma Ltd(AJANTPHARMPrice
52 Week High
₹3485
52 Week Low
₹1650.05

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹3121.15. It is down -10.44% from its 52 Week High price of ₹3485

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹3121.15. It is up 89.15% from its 52 Week Low price of ₹1650.05

Ajanta Pharma Ltd(AJANTPHARMReturns
1 Day Returns
-27.85%
1 Month Returns
7.36%
3 Month Returns
30.51%
1 Year Returns
88.9%